Trials / Conditions / Metastatic Salivary Gland Carcinoma
Metastatic Salivary Gland Carcinoma
4 registered clinical trials studyying Metastatic Salivary Gland Carcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers NCT05669664 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus NCT05408845 | NRG Oncology | Phase 2 |
| Recruiting | Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu NCT04704661 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer NCT04895735 | Mayo Clinic | Phase 2 |